RRC ID 43302
Author Takayama Y, Kokuryo T, Yokoyama Y, Nagino M, Nimura Y, Senga T, Hamaguchi M.
Title MEK inhibitor enhances the inhibitory effect of imatinib on pancreatic cancer cell growth.
Journal Cancer Lett.
Abstract Imatinib mesylate (imatinib) inhibits the c-Kit-dependent tyrosine kinase activities and highly effective in the treatment of CML and GIST patients. Although pancreatic cancer is reported to express c-Kit, imatinib does not effectively inhibit pancreatic cancer cell growth at physiological concentrations. Therefore, we investigated the mechanism of resistance of pancreatic cancer to imatinib treatment. Imatinib inhibited growth of pancreatic cancer cell lines in concentration and time-dependent fashion regardless of c-Kit expression. However, 5 microM imatinib, which is almost a mean maximal plasma concentration in clinical setting, failed to suppress pancreatic cancer cell growth. Western blot analysis demonstrated that 5 microM imatinib treatment for 1h activated the MEK-MAPK pathway and the activation was independent of Ras activation. Administration of 5 microM imatinib and 1 microM U0126 (MEK inhibitor) significantly suppressed pancreatic cell growth. Our results indicate that a combination therapy of imatinib and MEK inhibitor can be a new therapeutic strategy to suppress the progression of pancreatic cancer.
Volume 264(2)
Pages 241-9
Published 2008-6-18
DOI 10.1016/j.canlet.2008.01.035
PII S0304-3835(08)00068-2
PMID 18346844
MeSH Antineoplastic Combined Chemotherapy Protocols / pharmacology* Benzamides Blotting, Western Butadienes / pharmacology Cell Line, Tumor Cell Proliferation / drug effects Drug Resistance, Neoplasm / physiology* Enzyme Inhibitors / pharmacology* Extracellular Signal-Regulated MAP Kinases / drug effects Humans Imatinib Mesylate Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors* Mitogen-Activated Protein Kinase Kinases / drug effects Nitriles / pharmacology Pancreatic Neoplasms / drug therapy* Piperazines / pharmacology* Pyrimidines / pharmacology*
IF 6.491
Times Cited 16
WOS Category ONCOLOGY
Resource
Human and Animal Cells